Intra-articular hyaluronan in OA: mostly placebo effect?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1419, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intra-articular and oral tenoxicam: comparable benefits for OA

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?

By Scheen A.J.  

Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. : 873-888

Adis International

Access to resources Recommend Favorite

NSAIDs and the risk of CV events: is there a class effect?

By  

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Time to consider placebo effect in QOL studies in NSCLC?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 327, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Interferon-Beta in the Treatment of Multiple Sclerosis: Do Clinical Data Support the Existence of a Ceiling Effect?

By Clanet M.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 307-318

Adis International

Access to resources Recommend Favorite